CareLit Fachartikel

Generation and characterization of ganglidiximab for active immunotherapy of neuroblastoma

C Eger, D Brackrock, N Siebert, HN Lode · Klinische Pädiatrie · 2013 · Heft 05

Dokument
982085
CareLit-ID
Jahr
2013
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Klinische Pädiatrie
Autor:innen
C Eger, D Brackrock, N Siebert, HN Lode
Ausgabe
Heft 05 / 2013
Seiten
–
Erschienen: 2013-05-22 00:00:00
ISSN
0300-8630

Zusammenfassung

Introduction: Ganglidiomab is a murine IgG1 anti-idiotype antibody of anti-GD2 Ab ch14.18. We previously demonstrated an active GD2-specific humoral immune response against neuroblastoma (NB) after immunization of mice with ganglidiomab. To tailor this response to the murine variable regions in humans and to minimize nonspecific response against murine constant regions, we exchanged murine with human constant regions by Ab-engineering techniques. Methods and Results: Murine variable heavy (VH) and light chain (VL) cDNAs of ganglidiomab were identified, adapted by PCR and cloned into the pdHL7 vector in frame wit…

Schlagworte

Klinische Pädiatrie